- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Autoimmune Encephalitis in Finland
Total 324 results
-
Hoffmann-La RocheTerminated
-
BiogenCompletedRelapsing-remitting Multiple SclerosisBelgium, Denmark, Finland, Netherlands, Norway, Sweden, Switzerland, United Kingdom
-
US Department of Veterans AffairsCompletedMS (Multiple Sclerosis)United States
-
Turku University HospitalActive, not recruitingRheumatoid Arthritis | Vasculitis | Healthy Subjects | Pulmonary SarcoidosisFinland
-
University of OuluTurku University Hospital; Oulu University Hospital; Tampere University Hospital and other collaboratorsCompleted
-
University of OuluTurku University Hospital; Oulu University Hospital; Tampere University Hospital and other collaboratorsCompleted
-
Helsinki University Central HospitalFoundation for Paediatric Research, Finland; Päivikki and Sakari Sohlberg Foundation... and other collaboratorsCompletedJuvenile Idiopathic ArthritisFinland
-
Hoffmann-La RocheCompletedRheumatoid ArthritisFinland
-
University of HelsinkiActive, not recruitingType1diabetes | Celiac DiseaseFinland
-
Sormland County Council, SwedenKarolinska InstitutetCompletedRheumatoid Arthritis | Immunosuppression | Exposed to TBE-virusFinland, Sweden
-
Steno Diabetes Center CopenhagenFolkhälsan Researech CenterUnknownDiabetes Mellitus, Type 1 | AlbuminuriaDenmark, Finland
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisBelgium, Bulgaria, Canada, Croatia, Czech Republic, Finland, Germany, Hungary, Italy, Lithuania, Poland, Russian Federation, Serbia, Spain, Turkey, Ukraine, United Kingdom
-
Eli Lilly and CompanyBioMS Technology Corp.CompletedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Germany, Latvia, Netherlands, Spain, Sweden, United Kingdom
-
Hoffmann-La RocheCompletedAn Observational Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab)Rheumatoid ArthritisFinland
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1 | Delivery SystemsIsrael, Canada, Sweden, Finland
-
Eli Lilly and CompanyBioMS Technology Corp.TerminatedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Latvia, Spain, Sweden, United Kingdom, Germany, Netherlands
-
University of HelsinkiUniversity of Turku; Oulu University Hospital; Kuopio University Hospital; Seinajoki... and other collaboratorsUnknown
-
Tampere University HospitalTurku University Hospital; Helsinki University Central Hospital; Oulu University... and other collaboratorsCompletedType1diabetes | Insulin Resistance | Diabetic PregnancyFinland
-
NovartisCompletedMultiple SclerosisSwitzerland, Germany, Spain, Portugal, Canada, Denmark, Finland, France, Italy, Poland, United Kingdom
-
CSL BehringCompletedChronic Inflammatory Demyelinating PolyneuropathyPoland, France, Germany, Belgium, Finland
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisCroatia, Bulgaria, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Lithuania, Poland, Belgium, Hungary, Serbia, Finland, Ukraine, Switzerland, Canada, Turkey
-
SanofiCompletedMultiple SclerosisUkraine, Russian Federation, Estonia, Czech Republic, Denmark, Finland, France, Turkey, United Kingdom, United States, Portugal, Austria, Canada, Chile, Germany, Italy, Netherlands, Norway, Poland, Sweden, Switzerland
-
NovartisCompletedRelapsing Multiple SclerosisBelgium, Poland, Spain, France, United Kingdom, Guatemala, Canada, Finland, Switzerland
-
UCB PharmaBiogenTerminatedMultiple SclerosisUnited States, France, Germany, Spain, Canada, Netherlands, Belgium, Hungary, Sweden, United Kingdom, Finland
-
PfizerCompletedRheumatoid ArthritisSweden, Hungary, Denmark, Finland, Iceland, Norway
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...CompletedMultiple SclerosisUnited Kingdom, Germany, Finland, Israel, Spain, Canada, France, Australia, Czechia, Austria, Sweden, Poland, Hungary, Italy
-
Acorda TherapeuticsPRA Health SciencesCompletedMultiple SclerosisUnited States
-
University of HelsinkiNovo Nordisk A/S; Juvenile Diabetes Research Foundation; European Union; Academy... and other collaboratorsCompleted
-
Merck KGaA, Darmstadt, GermanyCompletedRelapsing-Remitting Multiple SclerosisGermany, Estonia, Latvia, Lithuania, Finland, Austria, Denmark, Netherlands, Portugal, Switzerland, Norway, Italy
-
Janssen Research & Development, LLCCompletedPre-Symptomatic Type 1 DiabetesUnited States, Finland, Sweden
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Medtronic DiabetesActive, not recruitingDiabetes type1 | Children, OnlyItaly, United Kingdom, Finland, Slovenia
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Novartis PharmaceuticalsTerminatedRelapsing Remitting Multiple Sclerosis (RRMS)Germany, Spain, Australia, Israel, Switzerland, Italy, Austria, Greece, Hungary, Czech Republic, Finland
-
BiogenCompletedMultiple SclerosisUnited States
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)CompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Canada
-
National Institute of Diabetes and Digestive and...National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaboratorsActive, not recruitingType 1 Diabetes MellitusUnited States, Finland, Germany, Sweden
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisHungary, Turkey, Spain, Germany, Canada, Switzerland, United States, Norway, Russian Federation, Italy, Finland, Poland
-
SanofiCompletedMultiple SclerosisFinland, Belgium, Spain, Chile, Norway, Italy, United States, Austria, Canada, France, Germany, Greece, Sweden, United Kingdom
-
Rigel PharmaceuticalsCompletedWarm Antibody Autoimmune Hemolytic AnemiaUnited States, Canada
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis | Clinically Isolated SyndromeCroatia, Bulgaria, France, Italy, Russian Federation, Spain, Estonia, Germany, Latvia, Poland, Romania, Argentina, Finland, Israel, Greece, Czech Republic, Slovakia, Austria, Belgium, Canada, Lebanon, Morocco, Portugal, Serbia
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple SclerosisUnited Kingdom, Germany, Israel, Finland, Canada, Australia, Czechia, Spain, France, Italy, Austria, Hungary, Poland, Sweden
-
BayerCompletedMultiple SclerosisSpain, Belgium, Czechia, Italy, United Kingdom, Hungary, Germany, Switzerland, Austria, France, Poland, Canada, Sweden, Finland, Israel, Denmark, Norway, Portugal
-
Novartis PharmaceuticalsCompletedRheumatoid ArthritisAustria, United Kingdom, Canada, Finland
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple SclerosisCroatia, Bulgaria, France, Italy, Russian Federation, Spain, Turkey, Estonia, Germany, Latvia, Poland, Romania, Argentina, Israel, Portugal, Greece, Czech Republic, Slovakia, Serbia, Austria, Finland, Saudi Arabia, Belgium, Canada, Lebanon and more
-
Universitaire Ziekenhuizen KU LeuvenActive, not recruitingDiabetes Mellitus, Type 1Belgium, Austria, Slovenia, Denmark, United Kingdom, Italy, Finland, Germany
-
NestléNestec Ltd.; Regulatory and Clinical Research Institute Inc; Cytel Inc.TerminatedStroke | Multiple Sclerosis | Parkinson Disease | Dementia | Alzheimer Disease | Oropharyngeal DysphagiaUnited States, Finland
-
BiogenCompletedMultiple SclerosisUnited States, Finland, Italy, United Kingdom, Bulgaria, Serbia, Russian Federation, Lithuania, Poland, Czech Republic, Netherlands
-
Hoffmann-La RocheCompletedMultiple Sclerosis, Relapsing-RemittingCanada, United States
-
University of Auckland, New ZealandCounties Manukau Health; Auckland Medical Research Foundation; Auckland District... and other collaboratorsUnknown